NT Mobile Menu

Search form


Sreeram Ramagopalan, PhD

Sreeram Ramagopalan, PhD

Sreeram Ramagopalan is a research fellow at the University of Oxford and Evidera, both in the United Kingdom. He is interested in the aetiology of multiple sclerosis and has published more than 200 research papers.

Posts by Author

ADHD lowers the quality of life in adults with epilepsy; epilepsy is associated with social deprivation and increased risk of venous thromboembolism: details of these recent findings in this slide show.

Three brand new studies shed light on use of natalizumab in relapsing-remitting multiple sclerosis.

Studies suggest that acupuncture can improve MS-related symptoms, but poor design makes it difficult to draw robust conclusions.

This, the least common MS disease course, carries the worst prognosis. Treatments are urgently needed to prevent or delay the rapid disease progression.

Childhood obesity is another potentially modifiable factor to reduce the risk of multiple sclerosis.

Hospitalization rates have declined dramatically in the MS population but remain higher than in the general population. That may be because of the availability of MS disease-modifying treatments.

Information on causes of death for patients with MS is limited, but these researchers came up with some of the underlying causes.

A significant percentage of patients with MS in the sample screened positive for 1 or more sleep disorders. Most were undiagnosed.

This study identified that suicidal thoughts are common and several potentially modifiable factors may be useful for prevention.

This study found a positive relationship between physical disability and anxiety and depression, pointing to a need for routine evaluation.


By clicking Accept, you agree to become a member of the UBM Medica Community.